Company · CIK 0001111485 · SIC 3851 — Ophthalmic Goods · Nasdaq
RxSight, Inc. · RXST
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 MForm 4 → | Sep 16, 4:25 pm EDT | Eric WeinbergSee remarks | 35,168 | $4.34 | $152,629 | 235,516 | — | |
| Sep 2, 2026 SForm 4 → | Sep 2, 9:35 pm EDT | Ronald M Kurtz M.D.Chief Medical Officer | 5,100 | $6.96 | $35,496 | 71,775 | −6.63% | |
| Sep 2, 2026 SForm 4 → | Sep 2, 9:35 pm EDT | Mark WilterdingChief Financial Officer | 7,765 | $6.96 | $54,044 | 25,049 | −23.7% | |
| Sep 2, 2026 SForm 4 → | Sep 2, 9:34 pm EDT | Ilya GoldshlegerChief Operating Officer | 2,041 | $6.96 | $14,205 | 81,509 | −2.44% | |
| Sep 2, 2026 SForm 4 → | Sep 2, 9:33 pm EDT | Eric WeinbergSee remarks | 2,041 | $6.96 | $14,205 | 200,348 | −1.01% | |
| Aug 31, 2026 MForm 4 → | Sep 2, 9:35 pm EDT | Ronald M Kurtz M.D.Chief Medical Officer | 13,425 | — | — | 76,875 | — | |
| Aug 31, 2026 MForm 4 → | Sep 2, 9:35 pm EDT | Mark WilterdingChief Financial Officer | 20,441 | — | — | 32,814 | — | |
| Aug 31, 2026 MForm 4 → | Sep 2, 9:34 pm EDT | Ilya GoldshlegerChief Operating Officer | 5,370 | — | — | 83,550 | — | |
| Aug 31, 2026 MForm 4 → | Sep 2, 9:33 pm EDT | Eric WeinbergSee remarks | 5,370 | — | — | 202,389 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 MForm 4 → | Sep 16, 4:25 pm EDT | Eric WeinbergSee remarks | 35,168 | — | — | 0 | — | |
| Sep 5, 2026 ADForm 4 → | Sep 9, 8:55 pm EDT | Mark WilterdingChief Financial Officer | 517,540 | — | — | 258,770 | — | |
| Sep 5, 2026 ADForm 4 → | Sep 9, 8:55 pm EDT | Eric WeinbergSee remarks | 783,712 | — | — | 93,984 | — | |
| Sep 5, 2026 ADForm 4 → | Sep 9, 8:53 pm EDT | Ronald M Kurtz M.D.Chief Medical Officer | 1,589,266 | — | — | 161,654 | — | |
| Sep 5, 2026 ADForm 4 → | Sep 9, 8:53 pm EDT | Ilya GoldshlegerChief Operating Officer | 849,599 | — | — | 93,984 | — | |
| Aug 31, 2026 MForm 4 → | Sep 2, 9:35 pm EDT | Ronald M Kurtz M.D.Chief Medical Officer | 13,425 | — | — | 67,120 | — | |
| Aug 31, 2026 MForm 4 → | Sep 2, 9:35 pm EDT | Mark WilterdingChief Financial Officer | 20,441 | — | — | 122,646 | — | |
| Aug 31, 2026 MForm 4 → | Sep 2, 9:34 pm EDT | Ilya GoldshlegerChief Operating Officer | 5,370 | — | — | 26,848 | — | |
| Aug 31, 2026 MForm 4 → | Sep 2, 9:33 pm EDT | Eric WeinbergSee remarks | 5,370 | — | — | 26,848 | — | |
| Jul 24, 2026 AForm 4 → | Jul 24, 8:07 pm EDT | Aziz MottiwalaPresident and CEO, Director | 2,883,424 | — | — | 571,286 | — |